Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio (2018 - 2026)

Amneal Pharmaceuticals' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.84 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 2.38% year-over-year to 0.84; the TTM figure through Mar 2026 stood at 0.84 (up 2.38% YoY), while the FY2025 annual figure was 0.84, up 4.95% from the prior year.
• Asset Utilization Ratio was 0.84 for Q1 2026 at Amneal Pharmaceuticals, up from 0.83 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.84 in Q1 2026 to a low of 0.12 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 0.54 across 5 years, with a median of 0.72 in 2024.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio plunged 123.4% in 2022, then soared 3255.08% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.12 in 2022, then soared by 640.15% to 0.67 in 2023, then increased by 20.03% to 0.8 in 2024, then gained by 3.36% to 0.83 in 2025, then grew by 1.73% to 0.84 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.84 (Q1 2026), 0.83 (Q4 2025), and 0.84 (Q3 2025), per Business Quant data.